Picture biomindz TRON LSE Mainz Translation Cancer Immunotherapy 650x100px

Organisation › Details

Gilead Sciences (Group)

https://www.gilead.com

	Start	1987-06-22 established
	Industry	biopharmaceutical
	Industry 2	virostatic agent
	Person	O’Day, Daniel (Gilead 201903– CEO before Roche Pharma CEO + COO + Roche Diagnostics COO joined Roche 1987)

	Street	333 Lakeside Drive
	City	94404 Foster City, CA
		Address record changed: 2024-01-05

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	27,305,000,000 (revenues, total, consolidated (2021) 2021-12-31)
	Profit	6,201,000,000 (2021-12-31)
	Cash	6,500,000,000 (2021-12-31)


		Record changed: 2024-02-06

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Gilead Sciences (Group)

[1] Tubulis GmbH. (12/3/24). "Press Release: Gilead and Tubulis Enter into Exclusive Option and Licence Agreement to Develop ADC Candidate for Select Solid Tumor Target". Foster City, CA & Munich....
[2] Hookipa Pharma Inc.. (12/21/23). "Press Release: Hookipa Pharma Announces $21.25 Million Equity Investment from Gilead Sciences". New York, NY & Vienna....
[3] Galapagos N.V.. (6/15/23). "Press Release: Galapagos Appoints Thad Huston as Chief Financial Officer and Chief Operating Officer". Mechelen....
[4] Hookipa Pharma Inc.. (1/4/23). "Press Release: Hookipa Pharma Achieves $5 Million Milestone Payment from Gilead Sciences for Progress in the Development of Hepatitis B Vaccine". New York, NY & Vienna....
[5] Gilead Sciences, Inc.. (9/20/22). "Press Release: Gilead Sciences Completes Acquisition of MiroBio". Foster City, CA....
[6] MiroBio Ltd.. (8/4/22). "Press Release: Gilead Sciences to Acquire MiroBio". Foster City, CA & Oxford....
[7] Galapagos N.V.. (8/30/21). "Press Release: Galapagos Announces Planned Retirement of CEO". Mechelen....
[8] BioNTech SE. (7/19/21). "Press Release: BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD". Mainz & Santo Monica, CA....
[9] Galapagos N.V.. (2/10/21). "Press Release: Galapagos and Gilead Discontinue ISABELA Phase 3 Trials in IPF". Foster City, CA & Mechelen....
[10] Gilead Sciences, Inc.. (1/6/21). "Press Release: Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors". Santa Monica, CA, Oxford & San Jose, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]